A detailed history of Bip Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bip Wealth, LLC holds 3,504 shares of NVO stock, worth $306,144. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,504
Previous 3,530 0.74%
Holding current value
$306,144
Previous $504 Million 17.2%
% of portfolio
0.03%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.07 - $145.42 $3,095 - $3,780
-26 Reduced 0.74%
3,504 $417 Million
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $3,190 - $3,819
26 Added 0.74%
3,530 $504 Million
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $122,736 - $163,375
1,202 Added 52.22%
3,504 $450 Million
Q4 2023

Feb 02, 2024

SELL
$87.78 - $105.45 $13,167 - $15,817
-150 Reduced 6.12%
2,302 $238 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $222,984 - $489,272
2,452 New
2,452 $223 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bip Wealth, LLC Portfolio

Follow Bip Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bip Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bip Wealth, LLC with notifications on news.